Interstrain differences in liver injury and one-carbon metabolism in alcohol-fed mice

Hepatology

Volumn 56, Issue 1, 2012, Pages 130-139

  Tsuchiya, Masato ^a,b   Ji, Cheng ^c   Kosyk, Oksana ^a   Shymonyak, Svitlana ^a   Melnyk, Stepan ^d   Kono, Hiroshi ^b   Tryndyak, Volodymyr ^e   Muskhelishvili, Levan ^e   Pogribny, Igor P ^e   Kaplowitz, Neil ^c   Rusyn, Ivan ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; GLUTATHIONE;

ALCOHOL LIVER DISEASE; ALCOHOLIC FATTY LIVER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBON METABOLISM; CONTROLLED STUDY; DIGESTIVE TRACT INTUBATION; DISEASE PREDISPOSITION; ENDOPLASMIC RETICULUM STRESS; ENVIRONMENTAL EXPOSURE; GENE; GENETIC VARIABILITY; HYPERHOMOCYSTEINEMIA; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; URINALYSIS;

ALCOHOLS; ANIMALS; BIOPSY, NEEDLE; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FATTY LIVER, ALCOHOLIC; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; METHIONINE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED STRAINS; ONE-CARBON GROUP TRANSFERASES; OXIDATIVE STRESS; RANDOM ALLOCATION; SEVERITY OF ILLNESS INDEX; SPECIES SPECIFICITY;

EID: 84863516824     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25641     Document Type: Article

References (48)

1. Li TK. Quantifying the risk for alcohol-use and alcohol-attributable health disorders: present findings and future research needs. J Gastroenterol Hepatol 2008; 23( Suppl 1): S2-S8.
2. Norstrom T, Ramstedt M. Mortality and population drinking: a review of the literature. Drug Alcohol Rev 2005; 24: 537-547.
3. McKillop IH, Schrum LW. Alcohol and liver cancer. Alcohol 2005; 35: 195-203.
4. Yip WW, Burt AD. Alcoholic liver disease. Semin Diagn Pathol 2006; 23: 149-160.
5. Breitkopf K, Nagy LE, Beier JI, Mueller S, Weng H, Dooley S. Current experimental perspectives on the clinical progression of alcoholic liver disease. Alcohol Clin Exp Res 2009; 33: 1647-1655.
6. Albano E, Vidali M. Immune mechanisms in alcoholic liver disease. Genes Nutr 2010; 5: 141-147.
7. Wilfred de Alwis NM, Day CP. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin Liver Dis 2007; 27: 44-54.
8. Druesne-Pecollo N, Tehard B, Mallet Y, Gerber M, Norat T, Hercberg S, et al. Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol 2009; 10: 173-180.
9. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461-1465.
10. Tian C, Stokowski RP, Kershenobich D, Ballinger DG, Hinds DA. Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet 2010; 42: 21-23.
11. Lu SC, Tsukamoto H, Mato JM. Role of abnormal methionine metabolism in alcoholic liver injury. Alcohol 2002; 27: 155-162.
12. Mato JM, Martinez-Chantar ML, Lu SC. Methionine metabolism and liver disease. Annu Rev Nutr 2008; 28: 273-293.
13. Obeid R, Herrmann W. Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS Lett 2009; 583: 1215-1225.
14. Frazer KA, Eskin E, Kang HM, Bogue MA, Hinds DA, Beilharz EJ, et al. A sequence-based variation map of 8.27 million SNPs in inbred mouse strains. Nature 2007; 448: 1050-1053.
15. Kono H, Bradford BU, Rusyn I, Fujii H, Matsumoto Y, Yin M, et al. Development of an intragastric enteral model in the mouse: studies of alcohol-induced liver disease using knockout technology. J Hepatobiliary Pancreat Surg 2000; 7: 395-400.
16. Thompson JA, Reitz RC. Effects of ethanol ingestion and dietary fat levels on mitochondrial lipids in male and female rats. Lipids 1978; 13: 540-550.
17. Kono H, Enomoto N, Connor HD, Wheeler MD, Bradford BU, Rivera CA, et al. Medium-chain triglycerides inhibit free radical formation and TNF-alpha production in rats given enteral ethanol. Am J Physiol Gastrointest Liver Physiol 2000; 278: G467-G476.
18. Nanji AA, Mendenhall CL, French SW. Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res 1989; 13: 15-19.
19. Bergmeyer HU. Methods of Enzymatic Analysis. New York: Academic Press; 1988.
20. Trasler J, Deng L, Melnyk S, Pogribny I, Hiou-Tim F, Sibani S, et al. Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice. Carcinogenesis 2003; 24: 39-45.
21. Shinohara M, Ji C, Kaplowitz N. Differences in betaine-homocysteine methyltransferase expression, endoplasmic reticulum stress response, and liver injury between alcohol-fed mice and rats. HEPATOLOGY 2010; 51: 796-805.
22. Bjorkegren J, Beigneux A, Bergo MO, Maher JJ, Young SG. Blocking the secretion of hepatic very low density lipoproteins renders the liver more susceptible to toxin-induced injury. J Biol Chem 2002; 277: 5476-5483.
23. Fischer M, You M, Matsumoto M, Crabb DW. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem 2003; 278: 27997-28004.
24. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GS. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003; 112: 91-100.
25. Qin Y, Tian YP. Exploring the molecular mechanisms underlying the potentiation of exogenous growth hormone on alcohol-induced fatty liver diseases in mice. J Transl Med 2010; 8: 120.
26. Li J, Nguyen V, French BA, Parlow AF, Su GL, Fu P, et al. Mechanism of the alcohol cyclic pattern: role of the hypothalamic-pituitary-thyroid axis. Am J Physiol Gastrointest Liver Physiol 2000; 279: G118-G125.
27. Ji C, Kaplowitz N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 2003; 124: 1488-1499.
28. Rutkowski DT, Wu J, Back SH, Callaghan MU, Ferris SP, Iqbal J, et al. UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. Dev Cell 2008; 15: 829-840.
29. Shaw S, Jayatilleke E, Ross WA, Gordon ER, Lieber CS. Ethanol-induced lipid peroxidation: potentiation by long-term alcohol feeding and attenuation by methionine. J Lab Clin Med 1981; 98: 417-424.
30. Lauterburg BH, Velez ME. Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. Gut 1988; 29: 1153-1157.
31. Christensen KE, Wu Q, Wang X, Deng L, Caudill MA, Rosen R. Steatosis in mice is associated with gender, folate intake, and expression of genes of one-carbon metabolism. J Nutr 2010; 140: 1736-1741.
32. Bradford BU, Rusyn I. Swift increase in alcohol metabolism (SIAM): understanding the phenomenon of hypermetabolism in liver. Alcohol 2005; 35: 13-17.
33. Cohen JI, Chen X, Nagy LE. Redox signaling and the innate immune system in alcoholic liver disease. Antiox Redox Signal 2011; 15: 523-534.
34. Ji C, Kaplowitz N. ER stress: can the liver cope? J Hepatol 2006; 45: 321-333.
35. Ji C. Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury. J Gastroenterol Hepatol 2008; 23: S16-24.
36. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004; 34: 9-19.
37. Han D, Hanawa N, Saberi B, Kaplowitz N. Mechanisms of liver injury. III. Role of glutathione redox status in liver injury. Am J Physiol Gastrointest Liver Physiol 2006; 291: G1-7.
38. Gramenzi A, Caputo F, Biselli M, Kuria F, Loggi E, Andreone P, et al. Review article: alcoholic liver disease-pathophysiological aspects and risk factors. Aliment Pharmacol Ther 2006; 24: 1151-1161.
39. Stickel F, Osterreicher CH. The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol 2006; 41: 209-224.
40. Harrill AH, Watkins PB, Su S, Ross PK, Harbourt DE, Stylianou IM, et al. Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. Genome Res 2009; 19: 1507-1515.
41. Roberts A, Pardo-Manuel dV, Wang W, McMillan L, Threadgill DW. The polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems genetics. Mamm Genome 2007; 18: 473-481.
42. Rutkowski DT, Arnold SM, Miller CN, Wu J, Li J, Gunnison KM, et al. Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol 2006; 4: e374.
43. Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol 2011; 54: 795-809.
44. Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 2011; 140: 1071-1083.
45. Walker AK, Jacobs RL, Watts JL, Rottiers V, Jiang K, Finnegan DM, et al. A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans. Cell 2011; 147: 840-852.
46. Fu S, Yang L, Li P, Hofmann O, Dicker L, Hide W, et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 2011; 473: 528-531.
47. Hultberg B, Berglund M, Andersson A, Frank A. Elevated plasma homocysteine in alcoholics. Alcohol Clin Exp Res 1993; 17: 687-689.
48. Blasco C, Caballeria J, Deulofeu R, Lligona A, Pares A, Lluis JM, et al. Prevalence and mechanisms of hyperhomocysteinemia in chronic alcoholics. Alcohol Clin Exp Res 2005; 29: 1044-1048.